The evaluation of Nesfatin-1 levels in patients with OSAS associated with metabolic syndrome

Journal of Endocrinological Investigation

Volumn 38, Issue 4, 2015, Pages 463-469

  Aksu, O ^a   Aydln, B ^a   Doguc D K ^a   Ilhan, I ^a   Ozturk, O ^a   Altuntas, A ^a   Demirkan, H ^a   Koroglu, B K ^a   Tamer, M N ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Metabolic syndrome; Nesfatin 1; Obstructive sleep apnea syndrome

Indexed keywords

GLUCOSE; INSULIN; NESFATIN 1 PROTEIN; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; DNA BINDING PROTEIN; NERVE PROTEIN; NUCLEOBINDIN;

ADULT; AGED; APNEA HYPOPNEA INDEX; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POLYSOMNOGRAPHY; PROTEIN BLOOD LEVEL; SLEEP DISORDERED BREATHING; ADOLESCENT; BLOOD; COMORBIDITY; MIDDLE AGED; OBESITY; SLEEP APNEA, OBSTRUCTIVE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CALCIUM-BINDING PROTEINS; COMORBIDITY; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NERVE TISSUE PROTEINS; OBESITY; SLEEP APNEA, OBSTRUCTIVE; YOUNG ADULT;

EID: 84937438362     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-014-0216-0     Document Type: Article

References (27)

1. American Academy of Sleep Medicine (2005) ICSD-2: the international classification of sleep disorders. diagnostic and coding manual, 2nd edn, Westchester, Illinois
2. Susheel PP, Hartmut S, Alan RS et al (2007) Adult obstructive sleep apnea-pathophysiology and diagnosis. Chest 132:325-337
3. Olson LG, Ching MT, Hensley MJ, Saunders NA (1995) A community study of snoring and sleep-disordered breathing. Prevalence. Am J Respir Crit Care Med 152:711-716
4. Fulop T, Tessier D, Carpentier A (2006) The metabolic syndrome. Pathol Biol (Paris) 54:375-386
5. Tiengo A, Fadini GP, Avogaro A (2008) The metabolic syndrome, diabetes and lung dysfunction. Diabetes Metab 34:447-454
6. Xu E, Schwab M, Marette A (2013) Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance. Rev Endocr Metab Disord 14:79-97
7. Oh-I S, Shimizu H, Satoh T et al (2006) Identification of Nesfatin-1 as a satiety molecule in the hypothalamus. Nature 12(443):709-712
8. Su Y, Zhang J, Tang Y, Bi F, Liu JN (2010) The novel function of nesfatin-1: antihyperglycemia. Biochem Biophys Res Commun 39:1039-1042
9. Jego S, Salvert D, Renouard L et al (2012) Tuberal hypothalamic neurons secreting the satiety molecule Nesfatin-1 are critically involved in paradoxical (REM) sleep homeostasis. PLoS ONE 7:52525
10. Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Insitute Scientific Statement. Circulation 112:2735-2752
11. Lindholm J (2013) Cushing's disease, pseudo-Cushing states and the dexamethasone test: a historical and critical review. Pituitary 17(4):374-380
12. Partinen M, McNicholas T (1998) Epidemiology, morbidity and mModeratelity of the sleep apnoea syndrome. Eur Respir Monograph 10:63-74
13. Yllmaz M, Bayazit YA, Ciftci TU et al (2005) Association of serotonin transporter gene polymorphism with obstructive sleep apnea syndrome. Laryngoscope 115:832-836
14. Soylu AC, Levent E, Sarlman N, Yurtlu S, Alparslan S, Saygl A (2012) Obstructive sleep apnea syndrome and anthropometric obesity indexes. Sleep Breath 16:1151-1158
15. Tuomilehto H, Seppä J, Uusitupa M (2013) Obesity and obstructive sleep apnea - clinical significance of weight loss. Sleep Med Rev 17:321-329
16. Schwab RJ, Goldberg AN, Pack AL (1998) Sleep apnea syndromes. In: Fishman AP (ed) Fishman' s pulmonary diseases and disorders. McGraw Hill Book Company, New York, pp 1617-1637
17. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670-676
18. Shimizu H, Oh-I S, Hashimoto K et al (2009) Peripheral administration of Nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 150:662-671
19. Su Y, Zhang J, Tang Y et al (2010) The novel function of nesfatin-1: anti-hyperglycemia. Biochem Biophys Res Commun 391:1039-1042
20. Cui H, Sohn JW, Gautron L et al (2012) Neuroanatomy of melanocortin-4 receptor pathway in the lateral hypothalamic area. J Comp Neurol 520:4168-4183
21. Abaci A, Catli G, Anik A, Kume T, Bober E (2013) The relation of serum Nesfatin-1 level with metabolic and clinical parameters in obese and healthy children. Pediatr Diabetes 14:189-195
22. Tang CH, Fu XJ, Xu XL, Wei XJ, Pan HS (2012) The anti-inflammatory and anti-apoptotic effects of Nesfatin-1 in the traumatic rat brain. Peptides 36:39-45
23. Pecchi E, Bonnet MS, Trouslard J, Jean A, Troadec JD, Dallaporta M (2009) Central nesfatin-1-expressing neurons are sensitive to peripheral inflammatory stimulus. J Neuroinflammation 6:27
24. Shen P, Han Y, Cai B, Wang Y (2014) Decreased levels of serum Nesfatin-1 in patients with obstructive sleep apnea syndrome. Sleep Breath. doi: 10.1007/s11325-014-1039-0
25. Vas S, Ádori C, Könczöl K et al (2013) Nesfatin-1/NUCB2 as a potential new element of sleep regulation in rats. PLoS ONE 8:59809
26. Fletcher EC (2000) Cardiovascular consequences of obstructive sleep apnea: experimental hypoxia and sympathetic activity. Sleep 23:127-131
27. Bez Y, Ari M, Ozturk OH, Oktar S, Can Y, Sogut S (2010) Plasma Nesfatin-1 level may be associated with disease severity in patients with panic disorder. BCP 20:288-292